• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

均衡供应商网络:医疗市场的谈判与排斥

Equilibrium Provider Networks: Bargaining and Exclusion in Health Care Markets.

机构信息

Department of Economics, Princeton University, Julis Romo Rabinowitz Building, Princeton, NJ 08544.

Department of Economics, Harvard University, Littauer Center, Cambridge, MA 02138.

出版信息

Am Econ Rev. 2019 Feb;109(2):473-522.

PMID:30707004
Abstract

We evaluate the consequences of narrow hospital networks in commercial health care markets. We develop a bargaining solution, "Nash- in-Nash with Threat of Replacement," that captures insurers' incentives to exclude, and combine it with California data and estimates from Ho and Lee (2017) to simulate equilibrium outcomes under social, consumer, and insurer- optimal networks. Private incentives to exclude generally exceed social incentives, as the insurer benefits from substantially lower negotiated hospital rates. Regulation prohibiting exclusion increases prices and premiums and lowers consumer welfare without significantly affecting social surplus. However, regulation may prevent harm to consumers living close to excluded hospitals.

摘要

我们评估了商业医疗保健市场中医院网络狭窄的后果。我们开发了一种讨价还价的解决方案,“纳什威胁替换”,它捕捉了保险公司排除的动机,并将其与加利福尼亚的数据和 Ho 和 Lee(2017)的估计结合起来,以模拟社会、消费者和保险公司最优网络下的均衡结果。排除的私人动机通常超过社会动机,因为保险公司从大幅降低的谈判医院费率中受益。禁止排除的规定会提高价格和保费,降低消费者福利,而不会显著影响社会盈余。然而,监管可能会防止对靠近被排除医院的消费者造成伤害。

相似文献

1
Equilibrium Provider Networks: Bargaining and Exclusion in Health Care Markets.均衡供应商网络:医疗市场的谈判与排斥
Am Econ Rev. 2019 Feb;109(2):473-522.
2
Insurer-Provider Networks in the Medical Care Market.医疗保健市场中的保险公司-供应商网络。
Am Econ Rev. 2009 Mar;99(1):393-430. doi: 10.1257/aer.99.1.393.
3
How do health insurer market concentration and bargaining power with hospitals affect health insurance premiums?健康保险公司的市场集中度以及与医院的议价能力如何影响医疗保险费用?
J Health Econ. 2015 Jul;42:104-14. doi: 10.1016/j.jhealeco.2015.03.009. Epub 2015 Apr 8.
4
Insurer Market Power Lowers Prices In Numerous Concentrated Provider Markets.保险市场势力降低了众多集中供应商市场的价格。
Health Aff (Millwood). 2017 Sep 1;36(9):1539-1546. doi: 10.1377/hlthaff.2017.0552.
5
Beyond Antitrust: Health Care And Health Insurance Market Trends And The Future Of Competition.超越反垄断:医疗保健和健康保险市场趋势与竞争的未来。
Health Aff (Millwood). 2017 Sep 1;36(9):1572-1577. doi: 10.1377/hlthaff.2017.0555.
6
Market Share Matters: Evidence Of Insurer And Provider Bargaining Over Prices.市场份额至关重要:保险公司与医疗服务提供商就价格进行讨价还价的证据。
Health Aff (Millwood). 2017 Jan 1;36(1):141-148. doi: 10.1377/hlthaff.2016.0479.
7
Hospital-insurer bargaining: an empirical investigation of appendectomy pricing.医院与保险公司的议价:阑尾切除术定价的实证研究
J Health Econ. 1997 Aug;16(4):417-34. doi: 10.1016/s0167-6296(96)00536-x.
8
Unchecked provider clout in California foreshadows challenges to health reform.加州未受制约的医疗服务提供者的影响力预示着对医改的挑战。
Health Aff (Millwood). 2010 Apr;29(4):699-705. doi: 10.1377/hlthaff.2009.0715. Epub 2010 Feb 25.
9
Switching benefits and costs in competitive health insurance markets: A conceptual framework and empirical evidence from the Netherlands.竞争型健康保险市场中的收益与成本转换:来自荷兰的概念框架与实证证据
Health Policy. 2015 May;119(5):664-71. doi: 10.1016/j.healthpol.2014.11.015. Epub 2014 Nov 29.
10
Market structure and hospital-insurer bargaining in the Netherlands.荷兰的市场结构与医院-保险公司的谈判
Eur J Health Econ. 2011 Dec;12(6):589-603. doi: 10.1007/s10198-010-0273-z. Epub 2010 Sep 19.

引用本文的文献

1
Commercial Price Variation in Ophthalmology.眼科的商业价格差异
JAMA Ophthalmol. 2025 Jul 3. doi: 10.1001/jamaophthalmol.2025.1693.
2
Commercial price variation for common imaging studies.常见影像学检查的商业价格差异。
Health Aff Sch. 2025 Apr 30;3(5):qxaf092. doi: 10.1093/haschl/qxaf092. eCollection 2025 May.
3
Commercial insurers' market power and hospital prices in Medicaid managed care.商业保险公司的市场势力与医疗补助管理式医疗中的医院价格
Health Serv Res. 2025 Feb;60(1):e14407. doi: 10.1111/1475-6773.14407. Epub 2024 Nov 9.
4
Medicare Part D Protected-Class Policy Is Associated With Lower Drug Rebates.医疗保险处方药部分受保护群体政策与更低的药品回扣相关。
Health Aff (Millwood). 2024 Oct;43(10):1420-1427. doi: 10.1377/hlthaff.2024.00273.
5
The consequences of firm scope and scale on patient access to healthcare.规模与范围对患者获得医疗服务的影响。
Health Serv Res. 2024 Apr;59(2):e14228. doi: 10.1111/1475-6773.14228. Epub 2023 Sep 26.
6
Considering the Effects of a Recent US Supreme Court's Ruling on Dialysis Care Costs.考虑到美国最高法院最近一项裁决对透析护理费用的影响。
Clin Ther. 2023 Mar;45(3):272-276. doi: 10.1016/j.clinthera.2023.01.015. Epub 2023 Feb 25.
7
Quality and Cost of Care by Hospital Teaching Status: What Are the Differences?医院教学地位对医疗质量和成本的影响:有何不同?
Milbank Q. 2021 Mar;99(1):273-327. doi: 10.1111/1468-0009.12502.
8
Comparison of Office-Based Physician Participation in Medicaid Managed Care and Health Insurance Exchange Plans in the Same US Geographic Markets.美国同一地理市场中,以办公室为基础的医生参与医疗补助管理式医疗和健康保险交易所计划的比较。
JAMA Netw Open. 2020 Apr 1;3(4):e202727. doi: 10.1001/jamanetworkopen.2020.2727.
9
Selection in Health Insurance Markets and Its Policy Remedies.健康保险市场中的选择及其政策补救措施。
J Econ Perspect. 2017;31(4):23-50. doi: 10.1257/jep.31.4.23.